<DOC>
	<DOCNO>NCT00574405</DOCNO>
	<brief_summary>Type I diabetes ( T1DM ) second common chronic illness effect child USA . Worldwide , Type I diabetes increase incidence , underlie etiology remain elusive . Nevertheless , recent data support notion early intensive management Type I diabetes 1 ) decrease long-term complication diabetes ; 2 ) may significantly improve beta cell function insulin secretion ensue year . To end , propose use insulin pump therapy preserve and/or enhance residual endogenous B-cell secretory capacity among patient newly diagnose Type 1 DM . Furthermore , anticipate early use insulin pump improve glycemic control beyond achieve standard multiple daily injection ( MDI ) therapy , well-tolerated patient . These data provide important pilot information explore potential role intensive insulin pump therapy treatment child newly diagnose Type I diabetes . The specific aim study test follow hypothesis : Early use insulin pump therapy effective preserving enhance residual endogenous pancreatic B-cell secretory capacity among patient newly diagnose T1DM : Moreover , early use insulin pump improve glycemic control beyond achieve standard multiple injection therapy , well-tolerated patient .</brief_summary>
	<brief_title>Preservation Pancreatic Beta Cell Function Through Insulin Pump Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Medical history clinical presentation consistent diagnosis Type 1 DM . Age : 818 year Clinical presentation consistent Type 2 DM . History chronic systemic inflammatory autoimmune disease severe medical condition . Concurrent pregnancy . Participation research protocol use investigational agent within 30 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Insulin pump</keyword>
	<keyword>Beta cell</keyword>
</DOC>